Dyax completes debt financing

Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Business: Inflammation, Ophthalmic, Antibodies Date completed: 1/4/12 Type: Debt financing Raised: $20 million Investor: Cowen Healthcare Royalty Partners N...